US Ruling Confirms Copaxone Is Not A Biologic
Legal Fight May Finally Be Over After District Court Ruling
US FDA’s interpretation of ‘protein’ is reasonable and owed deference, the court concludes in tossing Teva suit which challenged Copaxone’s exclusion from list of drugs transitioned to being regulated as biologics.
